Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.270
+0.180 (4.40%)
At close: May 12, 2025, 4:00 PM
4.270
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $262.65 million as of May 12, 2025. Its market cap has decreased by -4.24% in one year.
Market Cap
262.65M
Enterprise Value
-17.87M
1-Year Change
-4.24%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $262.65M, a decrease of -68.93%. That is a compound annual growth rate of -26.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 251.58M | -41.00% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |